![](https://investorshub.advfn.com/uicon/163809.png?cb=1649070668)
Monday, February 06, 2023 11:36:37 AM
But like I said, it will get gobbled up by Big Pharma before they allow that.
The best case scenario Is the stock remains public and we get a marketing partnership with Big Pharma.
The way these play out. FDA approval gets the mother of all runs. Then massive MM short, because it must then shown to actually sell. Then a buy out or marketing PR sends it into the stratosphere.
MITI, Micromet was a straight up buy out of all stock on potential. $3 to $14 over night. I’m still in a class action over the CEO selling out to low.
VMRLQ, Vernillion was an FDA approval. .05 to $5, then shorted below $2.50. Quest came out a week later with a marketing partnership snd it ran above $15. I’m still using those gains today playing these penny stocks.
This Alzheimer’s sector is Mega money. I can see a $B market cap easy. If it works and doesn’t kill everyone.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM